Cookie use on MRCVSonline
We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive all cookies.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Bova UK confirms omeprazole ‘free from testosterone’
“Many vets and horse owners now rely on long acting injectable omeprazole for horses that do not respond to oral treatment.”

New batch tested following concerns from the racing industry

Drug company Bova UK has confirmed its long-acting injectable omeprazole has been declared free from testosterone, after low levels were found in the product last month.

Supply of the product ceased in Australia after the initial discovery by the New South Wales racing authority.

Samples tested by the British Horseracing Authority (BHA) confirmed the issue extended to the UK and the racing body recently advised against using injectible omeprazole in racehorses.

Testing by the Australian Racing Forensic Laboratory (ARFL) did not detect testosterone in the newly prepared batch of Bova’s 100mg/ml injectable omeprazole formulation.

Racing New South Wales released a statement to confirm that the product can continue to be used in racehorses following the guidance of Australian Commonwealth and State legislation.

Nick Bova, the firm’s managing director, said: “Traces of testosterone in the previous batch were less than one millionth of the internationally accepted standard for impurities. Independent experts confirmed that there could be no adverse effects on equine health or equestrian sport, however, we have taken steps to identify and completely eliminate the excipient ingredient that contained traces of testosterone.

“Bova can confirm that new batches of this product will not contain the previous trace levels of testosterone and therefore Bova are confident there will be no antidoping issues, no matter what the equestrian pursuit is.”

He added: “Many vets and horse owners now rely on long acting injectable omeprazole for horses that do not respond to oral treatment.”

Following the news, the BHA issued an updated statement on the use of the product: “The BHA are aware of the most recent results from the batch analysed in Australia. Anyone treating thoroughbreds from birth to retirement from racing should consider the latest information, alongside that from analysis of previous batches, in deciding whether to use the product.”

 

Become a member or log in to add this story to your CPD history

Cats Protection launches Christmas animation

News Story 1
 Leading feline charity Cats Protection has launched a heartwarming Christmas animation to raise awareness of the important work it does. The animation is based on a true story of a kitten that went missing earlier this year. Freezing cold and hungry, the kitten was dumped in a box on a roadside and somehow became separated from her brother and sisters.


Thankfully there is a happy end to this tail, and Libby - now named Misty - was eventually reunited with her littermates. Misty’s owner, Amy Smith, said: “Misty has settled amazingly well into our home, she has found a best friend in my daughter Lily and likes to follow her around the house. She also loves to chase bugs in the garden. We feel very lucky to have her.” 

Click here for more...
News Shorts
WSAVA launches certificate programme focusing on companion animals in One Health

The first certificate programme focusing specifically on the role of companion animals in One Health has been launched by the One Health Committee (OHC) of the World Small Animal Veterinary Association (WSAVA).

The online programme, which is free of charge for WSAVA members, has been developed in recognition of the growing impact of companion animals in human society. Pet ownership is becoming more popular globally, and this has increased the implications for One Health, regarding the human-companion animal bond. The WSAVA OHC hopes that this course will bridge the knowledge gap between veterinary surgeons and human physicians. New modules are being added weekly, with a total of 20 modules expected to be available by early 2020.